One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 1months
-
http://medilib.ir
- Duration of Time : 31 Day
Price : 100$- Special Price : 50$
10 years after NOBLE: more nuance in left main revascularisation
Understanding where people with tuberculosis seek care to serve them better
The Lancet Commission on Skin Health: aligning with WHO priorities
Are India and China ready for a “chaotic surge� of generic obesity drugs?
Social habitus: a factory worker in a stroke rehabilitation unit in France
Returnees' health vulnerabilities after a 3-year conflict in Sudan
Asbestos, talc, and The Lancet's 1977 publication – Editors' reply
Clinical phenotyping improves choices of biologics in asthma – Authors' reply
Perioperative immunotherapy for resectable hepatocellular carcinoma
Perioperative immunotherapy for resectable hepatocellular carcinoma
Perioperative immunotherapy for resectable hepatocellular carcinoma – Authors' reply
Progress towards the WHO Global Initiative for Childhood Cancer target of 60% 5-year survival for all childhood cancers combined, 1990–2019 (CONCORD-4): a Cancer Survival Index derived for 68 countries by analysis of individual records for 613 021 children from 307 population-based cancer registries
Global burden of cancer in children and adolescents aged 0–19 years, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial
Pyruvate kinase activators in hereditary haemolytic anaemias: current evidence and clinical potential
